VeriMompotassium phenylbenzimidazole sulfonate est-il sûr pendant la grossesse ?
Potassium phenylbenzimidazole sulfonate (the water‑soluble salt of phenylbenzimidazole sulfonic acid, INCI often reported as Phenylbenzimidazole Sulfonic Acid/its salts) is a UVB filter with no harmonised reproductive classification and no convincing animal or human reproductive/toxic endocrine data in regulatory reviews; CIR/SCCS assessments do not identify reproductive hazard. Dermal absorption is low but measurable for this class of water‑soluble UV filters, so exposure in pregnancy is low but not zero (SCCS/CosIng/PubChem summaries).
Related ingredients
Frequently asked questions
- potassium phenylbenzimidazole sulfonate est-il sûr pendant la grossesse ?
- Potassium phenylbenzimidazole sulfonate (the water‑soluble salt of phenylbenzimidazole sulfonic acid, INCI often reported as Phenylbenzimidazole Sulfonic Acid/its salts) is a UVB filter with no harmonised reproductive classification and no convincing animal or human reproductive/toxic endocrine data in regulatory reviews; CIR/SCCS assessments do not identify reproductive hazard. Dermal absorption is low but measurable for this class of water‑soluble UV filters, so exposure in pregnancy is low but not zero (SCCS/CosIng/PubChem summaries).
- potassium phenylbenzimidazole sulfonate est-il sûr pendant l'allaitement ?
- Same rationale as for pregnancy: no regulatory harmonised reproductive or lactation hazard identified and no mechanistic evidence for transfer into milk in available safety assessments; dermal exposure is low but measurable, so postpartum topical use implies low maternal systemic exposure and therefore low likelihood of meaningful transfer into breast milk (SCCS/CosIng/PubChem).
- potassium phenylbenzimidazole sulfonate est-il sûr pour la peau de bébé ?
- No infant‑specific reproductive or developmental hazards reported; however, due to immature infant barrier and higher surface‑area‑to‑body‑weight, measurable dermal absorption of this water‑soluble UV filter warrants increasing exposure score for 0–3 year skin to moderate. Regulatory safety reviews (SCCS/CosIng) do not flag developmental or endocrine concerns but note exposure considerations for application to young children.
- Comment VeriMom évalue-t-il potassium phenylbenzimidazole sulfonate ?
- VeriMom évalue potassium phenylbenzimidazole sulfonate à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à potassium phenylbenzimidazole sulfonate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à potassium phenylbenzimidazole sulfonate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.